CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 107 filers reported holding CLOVIS ONCOLOGY INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $7,323,000 | +4.6% | 79,635 | -0.1% | 0.20% | +17.0% |
Q2 2015 | $7,003,000 | -66.4% | 79,685 | -71.6% | 0.17% | -68.3% |
Q1 2015 | $20,847,000 | -9.8% | 280,846 | -32.0% | 0.54% | -9.1% |
Q4 2014 | $23,120,000 | +30.3% | 412,857 | +5.6% | 0.59% | +22.0% |
Q3 2014 | $17,742,000 | +4.9% | 391,146 | -4.3% | 0.49% | +0.8% |
Q2 2014 | $16,917,000 | -9.5% | 408,529 | +51.4% | 0.48% | -20.4% |
Q1 2014 | $18,689,000 | -0.3% | 269,798 | -13.3% | 0.61% | +4.1% |
Q4 2013 | $18,752,000 | +25.8% | 311,132 | +26.9% | 0.58% | +19.0% |
Q3 2013 | $14,901,000 | +101.3% | 245,086 | +121.8% | 0.49% | -75.4% |
Q2 2013 | $7,401,000 | – | 110,490 | – | 1.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |